rhIGF-I/rhIGFBP-3

recombinant human insulin-like growth factor I / recombinant human insulin-like growth factor binding protein-3 · Insmed Incorporated

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rhIGF-I/rhIGFBP-3, covering 2022-01-06 to 2022-01-06. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGF-I/rhIGFBP-3) In Myotonic Dystrophy Type 1 [Phase 2]

See pricing